CVG CONTROLLED INC
Other · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $6.07B | $5.44B | $5.01B | $4.46B | $5.23B | $4.39B |
| Operating income | $1.26B | $1.38B | $1.31B | $1.50B | $1.69B | $897.6M |
| Net income | $1.07B | $4.17B | $1.40B | $1.52B | $1.50B | — |
| Total assets | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B |
| Total liabilities | $3.36B | $2.99B | $2.64B | $2.49B | $2.67B | $2.66B |
| Equity | $10.34B | $10.00B | $6.65B | $5.81B | $5.84B | $4.57B |
| EPS (diluted) | $1.83 | $6.97 | $2.30 | $2.44 | $2.38 | $1.30 |
| Shares out. | 587.9M | 601.3M | 608.3M | 623.2M | 624.5M | 209.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 20.8%
- Net margin
- 17.7%
- Return on equity
- 10.4%
- Return on assets
- 7.8%
- Return on capital (ROCE)
- 10.6%
- Liabilities / assets
- 24.5%
- Debt / equity
- 0.32×
- Book value / share
- $17.58
- Revenue growth (YoY)
- 11.5%
- Net income growth (YoY)
- −74.3%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 9.60safe
- Accruals / assets
- −3.8%clean
- Beneish M-Score
- -2.61normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Vanguard Capital Management LlcPassive (13G)Apr 29, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Blackrock, Inc.Passive (13G)Oct 17, 2025
- Wellington Management Group LlpPassive (13G)Aug 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Dahl Andrew M.Officer — SVP, Corporate Controller | May 29, 2026 | Sell | 567.527 | $86.08 |
| Bobo Donald E JrOfficer — CVP,Strategy/Corp Development | May 27, 2026 | Sell | 23,145 | $86.42 |
| Chopra DaveenOfficer — CVP, TMTT & Surgical | May 22, 2026 | Sell | 1,500 | $84.60 |
| Lippis Daniel J.Officer — CVP, TAVR | May 18, 2026 | Option exercise | 620 | $72.68 |
| Bobo Donald E JrOfficer — CVP,Strategy/Corp Development | May 15, 2026 | Sell | 9,968 | $82.07 |
| Zovighian Bernard JOfficer — CEO | May 11, 2026 | Option exercise | 47,207 | $0.00 |
| Bobo Donald E JrOfficer — CVP,Strategy/Corp Development | May 11, 2026 | Option exercise | 13,457 | $0.00 |
| Chopra DaveenOfficer — CVP, TMTT & Surgical | May 11, 2026 | Option exercise | 13,583 | $0.00 |
| Ullem Scott B.Officer — CVP, Chief Financial Officer | May 11, 2026 | Option exercise | 19,830 | $0.00 |
| Markowitz WayneOfficer — CVP, JAPAC | May 7, 2026 | Grant | 5,200 | $0.00 |
| Zovighian Bernard JOfficer — CEO | May 7, 2026 | Grant | 43,800 | $0.00 |
| Lippis Daniel J.Officer — CVP, TAVR | May 11, 2026 | Tax withholding | 362 | $79.96 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Director / officer change · Shareholder voteMay 8, 2026
- Director / officer change · Regulation FD disclosureMay 4, 2026
- Results of operationsApr 23, 2026
- Results of operationsFeb 10, 2026
- Regulation FD disclosureJan 12, 2026
- Director / officer change · Regulation FD disclosureOct 30, 2025
- Results of operationsOct 30, 2025
- Other material eventAug 19, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.